相关实验视频
Updated: Jan 17, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.3K
与健康人群相比,双相情感障碍中的工作障碍:系统性审查
Régio Marcos Abreu Filho1, Caroline Haussman Dos Santos2, Alberto José Filgueiras Gonçalves3
1Medicina, Faculdade Souza Marques, Rio de Janeiro, RJ, Brazil.
概括
患有双相情感障碍的人面临着严重的工作障碍和失业挑战. 即使在稳定的时期,保持就业也很困难,这会影响长期的职业前景.
科学领域:
- 精神病学是一个精神病学.
- 职业健康 职业健康 职业健康
- 心理健康研究 心理健康研究
背景情况:
- 双极性障碍 (BD) 是一种慢性精神健康状况,对就业有着重大,但研究不足的影响.
- 与一般人群相比,BD中的工作障碍和长期就业结果需要进一步调查.
研究的目的:
- 系统地审查和比较被诊断患有双相情感障碍的个体与健康的对照人群之间的工作障碍.
- 确定工作障碍的预测因素,并分析双相情感障碍对长期就业的影响.
主要方法:
- 使用PubMed/MEDLINE,SciELO和PsycINFO数据库进行了系统的文献审查.
- 搜索包括与双相情感障碍和工作/职业因素相关的术语,仅限于2013年至2023年的出版物.
- 选择了20篇评估就业能力和工作表现的文章进行分析.
主要成果:
- 双极性障碍的诊断显著增加了对失业的易感性和依赖政府援助的依赖性,因为它对行为,神经认知和情绪调节的影响.
- 对于那些患有BD的人来说,即使在临床稳定时期,保持与健康个体相匹配的就业是很有挑战性的.
- 抑郁症对就业的影响似乎与严重抑郁症,精神分裂情绪障碍和精神分裂症不同.
结论:
- 双极性障碍严重影响了就业能力和工作表现,对职业稳定产生长期影响.
- 目前,有效的干预措施来提高双相情感障碍患者的就业能力和生产力是有限的.
- 需要进一步的研究来制定有针对性的干预措施,以应对这一群体面临的独特就业挑战.
相关概念视频
01:30Bipolar Disorder
625
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
625
01:24Mania and Antimanic Drugs: Overview
553
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
553
01:27Depressive Disorders: MDD and Dysthymia
664
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
664
01:18Depression: Overview
794
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
794
01:27Depressive Disorders: Etiology
444
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
444
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
256
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
256